The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers

NCT02833389 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuropathic Diabetic Foot Ulcers

Interventions

DRUG: Placebo
DRUG: UTTR1147A

Sponsor

Genentech, Inc.